Research Article
Prevalence of Amiodarone-Induced Thyrotoxicosis and Associated Risk Factors in Japanese Patients
Table 2
Results of univariate Cox proportional hazards regression analysis.
| | | | HR (95% ) |
| | Gender | 0.965 | 0.967 (0.214–4.366) | | Age | <0.0001 | 0.927 (0.891–0.964) | | TSH | 0.457 | 0.814 (0.472–1.402) | | Free T3 | 0.476 | 1.388 (0.563–3.422) | | Free T4 | 0.925 | 1.137 (0.077–16.802) | | Cumulative dosage of AMD | 0.201 | 1.000 (0.999–1.000) | | Cardiac disorders | | | | Chronic heart failure | 0.732 | 0.048 (0.000–1651676) | | Low left ventricular function | 0.277 | 1.834 (0.615–5.463) | | Ischemic heart disease | 0.859 | 1.107 (0.361–3.389) | | Arrhythmia | | | | NSVT | 0.607 | 0.671 (0.147–3.071) | | Ventricular fibrillation | 0.218 | 0.298 (0.095–1.360) | | Atrial fibrillation | 0.928 | 1.099 (0.140–8.606) | | Cardiac medications | | | | -blocker | n/a | n/a | | -blocker | 0.214 | 0.274 (0.035–2.115) | | Anti-angiotensin agents | 0.534 | 0.664 (0.183–2.413) | | Anti-aldosteron agents | 0.246 | 0.516 (0.169–1.578) | | Diuretics | 0.889 | 1.083 (0.354–3.3118) | | Antithrombotic agents | 0.466 | 1.616 (0.444–5.882) | | Vasodilators | 0.888 | 1.114 (0.247–5.028) | | Calcium channel blocker | 0.914 | 1.087 (0.241–4.904) | | Antiarrhythmic agents | 0.478 | 22.97 (0.003–132741) |
|
|
NSVT: nonsustained ventricular tachycardia.
Confidence interval.
n/a: no assign.
|
